ABSTRACT: With a mass of ~1.6 x 10 7 Daltons and composed of approximately 2700 proteins, bacteriophage M13 has been employed as a molecular scaffold in bionanomaterials fabrication. In order to extend the versatility of M13 in this area, residue-specific unnatural amino acid incorporation was employed to successfully display azide functionalities on specific solvent-exposed positions of the pVIII major sheath protein of this bacteriophage. Employing a combination of engineered mutants of the gene coding for the pVIII protein, the methionine (Met) analog, L-azidohomoalanine (Aha), and a suitable Escherichia coli Met auxotroph for phage production, conditions were developed to produce M13 bacteriophage labeled with over 350 active azides (estimated by fluorescent dye labeling utilizing a strain-promoted azidealkyne cycloaddition) and capable of azide-selective attachment to 5 nm gold nanoparticles as visualized by transmission electron microscopy. The capability of this system to undergo dual labeling utilizing both chemical acylation and bioorthogonal cycloaddition reactions was also verified. The above stratagem should prove particularly advantageous in the preparation of assemblies of larger and more complex molecular architectures based on the M13 building block. Viral scaffolds are receiving intense interest for their use in materials and bionanomaterials [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . Owing to its well-defined architecture and the ability to finely control its structure through molecular biological [17] [18] [19] as well as chemical meth- , and bioelectronic devices such as solar cells and piezoelectric biobatteries 3, 5, 7, 13 . This filamentous virus (dimensions of approximately 6 nm x 900 nm), specific for Escherichia coli, is self-assembled at the bacterial membrane 19, 24 . The mature bacteriophage is composed of five copies of each of four different tip proteins: pIII, pVI, pVII, pIX, and approximately 2700 copies of the major coat protein, pVIII, which is helically arranged around the encapsulated viral DNA genome (Figure 1 ) 21, 25 . Modification of M13 with unnatural amino acids (UAA) has been accomplished on the pIII coat protein for phage display applications, although these studies did not assess the extent of UAA incorporation into M13 itself 17, 19, 26, 27 . Given the relatively low copy number of pIII subunits per M13 phage, more highly functionalized nano-scale materials could result from the engineering of the major coat protein pVIII without perturbing the pIII protein, a common site for the display of peptides having affinities to xenomaterials. For (bio)materials applications of M13, knowledge of the extent of UAA incorporation into M13 and the development of a system for multiple labeling capabilities are also essential.
posed of approximately 2700 proteins, bacteriophage M13 has been employed as a molecular scaffold in bionanomaterials fabrication. In order to extend the versatility of M13 in this area, residue-specific unnatural amino acid incorporation was employed to successfully display azide functionalities on specific solvent-exposed positions of the pVIII major sheath protein of this bacteriophage. Employing a combination of engineered mutants of the gene coding for the pVIII protein, the methionine (Met) analog, L-azidohomoalanine (Aha), and a suitable Escherichia coli Met auxotroph for phage production, conditions were developed to produce M13 bacteriophage labeled with over 350 active azides (estimated by fluorescent dye labeling utilizing a strain-promoted azidealkyne cycloaddition) and capable of azide-selective attachment to 5 nm gold nanoparticles as visualized by transmission electron microscopy. The capability of this system to undergo dual labeling utilizing both chemical acylation and bioorthogonal cycloaddition reactions was also verified. The above stratagem should prove particularly advantageous in the preparation of assemblies of larger and more complex molecular architectures based on the M13 building block. Viral scaffolds are receiving intense interest for their use in materials and bionanomaterials [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . Owing to its well-defined architecture and the ability to finely control its structure through molecular biological [17] [18] [19] as well as chemical methods [20] [21] [22] [23] , bacteriophage M13 has been employed in the fabrication of bionano-wires 10 , functional biomaterials [4] [5] [6] [7] [8] [9] , sensors or probes 1, 12, 15 , and bioelectronic devices such as solar cells and piezoelectric biobatteries 3, 5, 7, 13 . This filamentous virus (dimensions of approximately 6 nm x 900 nm), specific for Escherichia coli, is self-assembled at the bacterial membrane 19, 24 . The mature bacteriophage is composed of five copies of each of four different tip proteins: pIII, pVI, pVII, pIX, and approximately 2700 copies of the major coat protein, pVIII, which is helically arranged around the encapsulated viral DNA genome (Figure 1 ) 21, 25 . Modification of M13 with unnatural amino acids (UAA) has been accomplished on the pIII coat protein for phage display applications, although these studies did not assess the extent of UAA incorporation into M13 itself 17, 19, 26, 27 . Given the relatively low copy number of pIII subunits per M13 phage, more highly functionalized nano-scale materials could result from the engineering of the major coat protein pVIII without perturbing the pIII protein, a common site for the display of peptides having affinities to xenomaterials. For (bio)materials applications of M13, knowledge of the extent of UAA incorporation into M13 and the development of a system for multiple labeling capabilities are also essential.
To achieve this, we show that the residue specific incorporation of L-azidohomoalanine (Aha), an analog of the amino acid methionine (Met), into Met positions in pVIII is possible when infecting a Met auxotrophic strain of E. coli (ER2738 metE) with engineered variants of M13 under specific media conditions. E. coli strain ER2738 was utilized to provide the F' required for M13 infection. As well, inactivation of the metE gene (ΔmetE774::kan) in ER2738 was constructed by P1 vir transduction to block E. coli Met biosynthesis and eliminate competition from endogenously biosynthesized methionine. Successful labeling of pVIII utilizing the displayed azide was accomplished using strain-promoted azide-alkyne cycloaddition (SPAAC; Figure 1) 
28
. The pVIII protein is highly tolerant to mutagenesis and contains only a few epitopes that result in a large loss of viability when changed 29 . Constructing several variants of M13 that repositioned a Met residue (and therefore the Aha analog) for optimum solvent exposure enhanced the availability of this azide group for phage surface modification on the mature pVIII coat protein ( Figure 1 ).
Of the three Met residues present in pro-pVIII, two are removed by the host E. coli leader peptidase before phage extrusion ( Figure 1 ). The Met residues at positions -5 and 28 were replaced by leucines prior to substituting Met at position 9 (M13 A9M ), 13 (M13 S13M ) or 16 (M13 A16M ) by recombinant DNA techniques in order to counter any possible effects in phage production levels caused by substitutions by Aha at these non-strategic Met positions in pVIII. Net phage production for each variant was compared with that of WT M13 (M13 WT ) at 4.5 hours in order to obtain a measure of phage viability. The M13 variants produced under these conditions resulted in some loss of viability ranging from 3.0-fold to 7.7-fold compared to M13 WT (Supplementary Figure 1a) . Of the three single Met variants, M13 A16M viability was the lowest. The A16M mutation might interfere with the stacking of adjacent pVIII subunits compared to positions A9 and S13 that are more exposed in the N-terminal region of pVIII. In a randomized mutagenesis study on pVIII, the positions A9, S13 and A16 were found to be highly variable 30 . The mutability of pVIII was consistent with the good yields of variants produced in this current study. With the availability of several viable bacteriophage variants containing relocated Met positions on their surface exposed pVIII proteins, investigations on unnatural amino acid bioincorporation into pVIII were undertaken. It has been established that Aha can compete with Met and be charged onto tRNA by methionyl-tRNA synthetase 31 . Notably, when an amino acid auxotrophic strain of E. coli is grown in media containing the UAA of interest, incorporation of the UAA occurs [31] [32] [33] [34] [35] . Additionally, recent metabolic engineering work has demonstrated that Aha can be intracellularly produced 36 .
The added challenge of incorporation of Aha into M13 during the process of phage infection and replication, which includes the complex production of eleven different phage proteins (pI-pXI), some of which are not components of the mature M13 phage but are required to be functional, was successfully met by optimization of both Aha and Met levels in the bacterial growth medium (Supplementary Figure 1) .
Incorporation of Aha into pVIII was confirmed by electrospray ionization mass spectrometry (ESI-MS). The major mass peak (5279 Da) observed for pVIII in a spectrum of M13 A9M grown in the absence of Aha was consistent with the theoretical mass of pVIII A9M (5280 Da; Figure 2 and Supplementary Figure 2 ). When M13 A9M was produced in the presence of 10 mM Aha and 235 µM Met, an additional protein with a mass of 5274 Da was observed which corresponded to the expected mass of pVIII A9M containing Aha (Figure 2 ). This expected mass difference of -5 Da was also observed in the mass spectra of pVIII S13M and pVIII WT analyzed from phage that were grown in the presence of Aha (Supplementary Figures 3 and 4) . The relative intensities of the Aha-pVIII peaks were 10-13% of the Met-pVIII peak in each case. The negative control, M13 M-5/28L , lacked the associated peak at -5 Da from the major pVIII peak (Supplementary Figure 5) . A9M and pVIII S13M , Aha is expected to have occurred at positions 28, 9 and 13 on pVIII respectively. Critical to future applications of M13 as a multivalent nanoparticle is the proof-of-concept of successfully applying bioorthogonal-labeling chemistries to the above Ahacontaining bacteriophage 31, 37 . The SPAAC reaction was utilized here with an aza-dibenzocycloocytne (DIBAC) reactive group, which was designed by Debets, M.F. and co-authors to have both fast kinetics and favourable solubility in water 28 . Aha-containing M13 was reacted with DIBAC-PEG 4 -tetramethylrhodamine (DIBAC-PEG 4 -TAMRA) and the absorbance spectra of the labeled phages were used to estimate the incorporation efficiency of Aha. Labeling of M13 A9M was confirmed by mass spectrometry experiments (Figure 2 ). The very low TAMRA absorbance in phages grown in the absence of Aha indicated that the washing procedure effectively removed non-specifically bound DIBAC-PEG 4 -TAMRA ( Figure  3) . The TAMRA-labeled M13 phages exhibited a visible absorbance spectrum with a maximum at 556 nm and a shallow secondary maximum at 518 nm, corresponding to the absorbance of TAMRA 38, 39 . M13 A9M and M13 S13M were labeled equally well at 14 ± 2 % and 13 ± 2 % respectively and suggest that 13-14 % of pVIII subunits had Aha incorporated. M13 WT labeling was lower at 5 ± 1 % of pVIII subunits labeled. M13 WT was not expected to react to completion since structural studies on pVIII have indicated that Met28 which is present in M13 WT is not likely exposed to the solvent 40 . Labeling of M13 WT in this study could be attributed to the flexibility of M13 itself allowing exposure of a fraction of the Aha28 residues for reaction 41 . The percentages of incorporation of Aha estimated here were similar to that observed for adenovirus coat protein labeling using a media replacement strategy, although in the current M13 study an intact bacteriophage has been labeled 42 . As a negative control, M13 M-5/28L grown in (Figure 3 ). Using the same mathematical treatment, the extent of labeling was estimated at 1.4 ± 1 %. This control suggests that labeling with DIBAC is specific to pVIII with an azide incorporated. Furthermore, it was expected that this labeling strategy would be orthogonal to other common protein labeling strategies. Indeed, when carried out together with acylation by NHS-sulfo-cy7 (an amine specific reagent), dual-labeling of M13 A9M -Aha with both dyes occurred as expected. For A9M, dual-labeling was observed as evidenced by the TAMRA peak at 556 nm and the sulfo-cy7 peak at 750 nm (Figure 3e) . Consistent with the other results for SPAAC labeling of M13 the labeling efficiency of DIBAC-TAMRA was 15.5 % for dual-labeled M13. The M13 M-5/28L negative control did not react with DIBAC-TAMRA at all regardless of the growth conditions (Figure 3f ). As expected, NHS-sulfo-cy7 reacted with both variants and regardless of whether they were grown in the presence or absence of Aha. Dual-labeling on single M13 particles was also verified by dual-labeling followed by affinity isolation experiments. When DIBAC-biotin was reacted alongside NHS-sulfo-cy7 to produce dual-labeled A9M-Aha, the sulfo-cy7 absorbance signal could be used to track separation of biotinylated M13 using streptavidin (SA) magnetic particles (Supplemental Figures 14 and 15 ). These additional experiments are consistent with the occurrence of dual-labeling resulting in a population of M13 conjugated with two different labels on the same M13 particle. For visual inspection of bioorthogonal labeling using TEM, M13 variants with displayed azides were reacted with DIBAC-PEG 4 -biotin and incubated with streptavidin-labeled AuNPs (SA-AuNPs). Uniformity of distribution of AuNPs was seen in M13 A9M and M13 S13M grown with 10 mM Aha and 235 µM Met (Supplementary Figure 6 and Figure 4) . When biotin-labeled M13 and SA-AuNPs were incubated together the average numbers of AuNPs observed bound to each phage particle were 54 ± 19 and 57 ± 15 for M13 A9M and M13 S13M respectively (Supplementary Figure 7) . The differences in contrast seen in some images can be attributed to differences in stain density between grid preparations. In the samples grown in the absence of Aha, a small number of AuNPs can be seen associating with M13 phages, but substantially fewer than the Aha-labeled phages (Figure 4 and Supplementary  Figure 6) . In M13 WT , as the azide would be positioned at the interface between pVIII subunits, it is possible that adduct formation interferes with the stability of assembled M13. In this regard the structures of M13 WT phages post-reaction appeared twisted and aggregated (Supplementary Figure 8) . As well, the extent of M13 WT labeling was much lower than for the M13 A9M and M13 S13M variants (Supplementary Figure 7) . The M13 M-5/28L bacteriophage produced with Aha was only able to bind 6 ± 3 AuNPs per phage on average, likely due to non-specific interactions (Supplementary Figure 9) . It is possible that the number of associated AuNPs visualized by TEM under-represents the actual number of pVIII subunits with incorporated Aha. Due to the relatively large size of the AuNPs, it is expected that not all Aha-pVIII subunits have a AuNP associated with them. The TEM results were also reflected in the mass spectra of biotin-labeled phages, in which only for M13 A9M and M13 S13M could the biotin label be detected (Supplementary Figures 10-13 ). The goal of this research was to develop an enabling M13 bioincorporation strategy which would provide labeling sites capable of modification by methods orthogonal to the standard chemical labeling methods that have been previously utilized 21 . The research reported herein has successfully demonstrated UAA incorporation into the pVIII protein of an entire bacteriophage M13 and has demonstrated the capabilities of these phages to be further modified, providing enhanced versatility in a viral scaffold which frequently has been employed as a component in diverse applications [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] .
This approach complements the currently available M13 toolset and provides additional possibilities for bottom-up biomaterial fabrication. Using orthogonal methods to organize varied components onto such a scaffold in a controlled manner is expected to introduce new possibilities to the field of phage-based bionanomaterials.
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